Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Rigel ( (RIGL) ) is now available.
Dr. Brian Kotzin has decided to step down from his role as an independent director on Rigel Pharmaceuticals’ Board of Directors, as well as from all board committees he serves on, effective September 16, 2024. His resignation is amicable and not due to any disputes concerning Rigel’s operational, policy, or practice matters.
Find detailed analytics on RIGL stock on TipRanks’ Stock Analysis page.
